Table 4.
Intervention group N = 69 |
Control group N = 33 |
Model A N = 102 |
Model B N = 96 |
|||||
---|---|---|---|---|---|---|---|---|
Mean (sd) | Mean (sd) | B (95% CI) | P value | d | B (95% CI) | P value | d | |
ADL limitations | ||||||||
Baseline | 0.23 (0.86) | 0.33 (0.69) | ||||||
9 months | 0.23 (0.73) | 0.42 (0.71) | − 0.10 (− 0.19 to − 0.004) | .04 | .12 | − 0.11 (− 0.21 to − 0.01) | .03 | .14 |
Experienced frailty | ||||||||
Baseline | 0.11 (0.07) | 0.12 (0.07) | ||||||
9 months | 0.11 (0.06) | 0.11 (0.07) | 0.00 (− 0.01 to 0.01) | .46 | 0 | 0.00 (− 0.00 to 0.01) | .33 | 0 |
Mental health | ||||||||
Baseline | 81.67 (11.00) | 79.96 (13.94) | ||||||
9 months | 81.07 (12.85) | 83.52 (11.61) | − 2.50 (− 4.51 to − 0.50) | .02 | .21 | − 2.48 (− 4.62 to − 0.34) | .02 | .21 |
Intervention group N = 39 |
Control group N = 23 |
Model A N = 62 |
Model B N = 56 |
|||||
Mean (sd) | Mean (sd) | B (95% CI) | P value | d | B (95% CI) | P value | d | |
Depressive symptoms | ||||||||
Baseline | 8.92 (6.05) | 8.35 (6.67) | ||||||
9 months | 7.64 (5.72) | 8.30 (7.35) | − 0.67 (− 1.95 to 0.60) | .30 | .11 | − 0.86 (− 2.27 to 0.55) | .23 | .14 |
Model A: adjusted for y at baseline, age, and sex. Model B: adjusted for y at baseline, age, sex, education, and ApoE-ε4 carrier status. PA Physical activity as measured in daily number of steps taken, ADL Activities of daily living, IGF-I Insulin-like growth factor 1, HDL High-density lipoprotein, d Cohen’s d